Skip to main content
v2026.11,986 entries · CC-BY 4.0

Ageing Research Reviews: Scope, Impact Factor, APC and Submission Guide

Guide to Ageing Research Reviews covering its 15.5 Impact Factor, scope across cellular senescence, APC rates, and editorial submission workflow.

Written and maintained by CASRAI Editorial Board

Published

On this page

Ageing Research Reviews (ISO abbreviation: Ageing Res. Rev.) is a peer-reviewed biomedical review journal published by Elsevier that covers the molecular mechanisms, cellular biology, and clinical pathophysiology of ageing and age-associated diseases. Holding a 2024–2025 Journal Impact Factor of 15.5 and a Scopus CiteScore of 24.1, the journal operates as a hybrid publication offering subscription and gold open-access tracks with an article publishing charge (APC) of $5,460 USD.

What it is

Ageing Research Reviews is an international, multidisciplinary scholarly journal dedicated exclusively to the synthesis and critical analysis of ageing biology, longevity pathways, and late-life pathologies. Established in 2002 and published continuously by Elsevier on a monthly publishing schedule (12 issues per year), the journal serves biomedical scientists, molecular biologists, geriatricians, and translational researchers seeking comprehensive assessments of emerging paradigms rather than primary laboratory reports.

Bibliographically, the publication is catalogued under Print ISSN 1568-1637 and Electronic ISSN 1872-9649, with the ISO 4 title abbreviation standardized as Ageing Res. Rev. (NLM Unique ID: 101128963). In the publishing landscape of biogerontology, the journal occupies a specialized role: it enforces a strict review-only mandate. Unlike traditional biomedical periodicals that prioritize original bench research, Ageing Research Reviews commissions and accepts syntheses that integrate disparate empirical findings, reconcile conflicting experimental models, and propose forward-looking theoretical frameworks.

The journal’s bibliometric performance reflects its high citation density. According to Clarivate’s 2024–2025 Journal Citation Reports (JCR), the publication maintains a Journal Impact Factor of 15.5, positioning it firmly in the first quartile (Q1) across both the “Geriatrics & Gerontology” and “Cell Biology” categories. Similarly, in the Scopus database, its CiteScore stands at 24.1, placing it in the 98th to 99th percentile among international journals in aging, biochemistry, genetics, and molecular biology. The journal is indexed comprehensively across major scholarly databases, including MEDLINE/PubMed, the Science Citation Index Expanded (SCIE / Web of Science Core Collection), Scopus, Embase, and BIOSIS Previews.

From an economic and operational perspective, Ageing Research Reviews functions as a hybrid journal (classified as a Transformative Journal under Plan S guidelines). Authors have the flexibility to publish through the traditional subscription route at zero author fees, where published articles are accessed through university subscriptions or institutional licenses. Alternatively, authors can elect the Gold Open Access track by paying an Article Publishing Charge (APC) of $5,460 USD (or €4,900 EUR / £4,220 GBP, exclusive of value-added tax), which makes the final published article immediately freely accessible under Creative Commons licenses (typically CC BY 4.0 or CC BY-NC-ND 4.0). Many researchers publishing in the journal have their APC covered through institutional transformative “read-and-publish” agreements negotiated between Elsevier and national library consortia.

Who runs it and what it covers

Ageing Research Reviews is published under the health sciences and life sciences imprint of Elsevier B.V. (headquartered in Amsterdam, Netherlands). The journal’s academic governance is led by Editor-in-Chief Claudio Franceschi, Emeritus Professor of Immunology at the University of Bologna and a pioneer in geroscience, known internationally for formulating the concept of inflammaging and deciphering the genetics of human centenarians. Professor Franceschi is supported by an international editorial board composed of leading investigators across cellular senescence, regenerative biology, neurobiology, and clinical gerontology.

The editorial scope of the journal is intentionally broad in disease relevance but strictly focused on mechanistic rigor. Rather than accepting purely descriptive reviews, the editors require submissions to clarify underlying biochemical, molecular, and physiological pathways. Core thematic domains include:

  • Primary Hallmarks of Biological Ageing: In-depth syntheses addressing genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication, connecting directly to the codified hallmarks of aging.
  • Neurodegenerative Disorders: Molecular pathways governing Alzheimer’s disease, Parkinson’s disease, vascular dementia, and amyotrophic lateral sclerosis (ALS), emphasizing neuroinflammation, microglial activation, protein misfolding (amyloid-beta, tau, alpha-synuclein), and blood-brain barrier breakdown.
  • Cardiovascular and Metabolic Senescence: Pathophysiology of vascular stiffness, endothelial dysfunction, atherosclerosis, cardiac hypertrophy, insulin resistance, type 2 diabetes mellitus, and age-dependent adipose tissue remodeling.
  • Immunosenescence and Inflammaging: Chronic, sterile low-grade systemic inflammation, T-cell repertoire exhaustion, immune checkpoint regulation, and the senescence-associated secretory phenotype (SASP).
  • Therapeutic Interventions and Geroscience: Preclinical and clinical evaluations of senolytics, senomorphics, calorie restriction mimetics (e.g., rapamycin, metformin, NAD+ precursors), epigenetic reprogramming, and exercise physiology.

To address these domains, the journal publishes three primary article types. Critical Reviews (typically 8,000 to 12,000 words) form the core of each issue, providing comprehensive, authoritative treatments of mature research areas alongside newly developed conceptual illustrations. Short Reviews (or Mini-Reviews, 4,000 to 6,000 words) deliver rapid, timely syntheses of emerging techniques, controversial findings, or newly discovered signalling nodes. Viewpoints offer targeted, scholarly perspectives on theoretical models or public policy implications of ageing research. Additionally, systematic reviews and meta-analyses that comply with PRISMA reporting standards are considered when addressing high-priority clinical or translational debates.

How to search or use it

Interacting with Ageing Research Reviews encompasses two distinct user pathways: literature search and discovery on the ScienceDirect platform, and manuscript preparation and submission via Elsevier’s Editorial Manager system.

Searching and Accessing Content on ScienceDirect

Readers and researchers can discover articles directly through ScienceDirect by following systematic search procedures:

  1. Navigate to Journal Home: Access the dedicated journal portal on ScienceDirect (sciencedirect.com/journal/ageing-research-reviews).
  2. Execute Advanced Queries: Utilize the “Search in this journal” interface. Combine targeted keywords using Boolean operators (e.g., "cellular senescence" AND "mitochondria") to locate review articles covering specific molecular cross-talk.
  3. Filter by Access Type: Use the left-hand faceted navigation filters to isolate “Open Access” articles if searching outside an institutional proxy or subscription network.
  4. Track Articles in Press: Select the “Articles in press” tab to access uncorrected proofs and accepted manuscripts before formal volume assignment, ensuring access to cutting-edge findings weeks ahead of print issue compilation.
  5. Leverage ScienceDirect Topic Pages: Hyperlinked biomedical terms within article abstracts connect directly to Elsevier’s automated Topic Pages, allowing readers to explore adjacent biochemical definitions and related literature.

Manuscript Preparation and Submission Workflow

For authors preparing a review manuscript, adherence to the official Guide for Authors is essential to pass initial editorial screening. The standard workflow follows eight concrete stages:

  1. Verify Review Eligibility: Confirm that the manuscript is a synthetic, critical review or meta-analysis; original experimental papers and single uncorroborated laboratory studies are not accepted. Authors uncertain of fit may send a presubmission inquiry with an extended outline to the editorial office.
  2. Format Abstract and Highlights: Prepare a non-structured or structured abstract of maximum 250 words outlining the review’s core mechanistic insights and conclusions. Draft 3 to 5 “Highlights” (each a maximum of 85 characters including spaces) that summarize the distinctive takeaways.
  3. Structure Text and High-Resolution Figures: Structure the body with clear numbered headings. Because review papers rely heavily on conceptual visual models, provide publication-quality schematic diagrams illustrating molecular pathways at a minimum resolution of 300 DPI in TIFF or EPS format.
  4. Apply Elsevier Harvard Reference Style: Format citations using the author-date system. In text, cite author surnames and publication year (e.g., Franceschi and Campisi, 2014; or Lopez-Otin et al., 2023 for three or more authors). Compile references alphabetically at the end of the manuscript, using ISO 4 journal abbreviations and including digital object identifiers (DOIs) where available.
  5. Compile Mandatory Declarations: Prepare separate declarations for CRediT author contributions, Conflict of Interest statements, Funding source disclosures, and declarations regarding the use of generative artificial intelligence tools in manuscript preparation.
  6. Submit via Editorial Manager: Access the submission portal at editorialmanager.com/arr/. Select the appropriate Article Type (Critical Review, Short Review, or Viewpoint), upload the manuscript document (DOCX or LaTeX), and provide separate figure and table files. The journal supports “Your Paper Your Way” during initial submission, permitting freeform layout provided formatting consistency is maintained.
  7. Suggest Expert Reviewers: Nominate 3 to 5 independent expert reviewers who have published actively in the subject matter within the past three years. Nominated referees must not share institutional affiliations, recent co-authorships, or financial conflicts with any of the authors.
  8. Navigate Single-Blind Peer Review: The journal employs a standard single-blind (single-anonymous) peer review model, in which external referees know author identities while referees remain anonymous. Initial editorial triage typically concludes within 1 to 3 weeks, followed by external review. Authors receiving revision requests must submit point-by-point rebuttal letters and tracked-change manuscripts. Unaccepted submissions may be offered transfer options through Elsevier’s cascading peer review service to alternative specialty journals.

Strengths and limits

Evaluating Ageing Research Reviews requires weighing its bibliometric prestige and dissemination reach against its editorial selectivity and structural boundaries.

Key Strengths

  • Exceptional Citation Velocity: With an Impact Factor of 15.5, papers published in the journal achieve rapid indexation and substantial citation frequency, making it one of the most visible outlets for career benchmarking and grant reporting in biomedical research.
  • Comprehensive Global Reach: ScienceDirect’s pervasive deployment across academic institutions worldwide ensures that published articles reach research laboratories, medical schools, and biopharmaceutical institutions globally.
  • No Mandatory Author Charges: Because the journal retains a robust subscription model alongside open access, authors without discretionary grant funding or institutional subsidy can publish at zero personal or institutional cost.
  • Dedicated Review Format: Authors have sufficient word budgets (8,000 to 12,000 words) to conduct deep mechanistic analyses and include comprehensive pathway diagrams that smaller general-interest journals cannot accommodate.

Limitations and Practical Constraints

  • Exclusion of Primary Research: Laboratories seeking to publish empirical bench experiments, novel animal model phenotypic assays, or clinical trial outcomes cannot submit their primary data here; the venue is reserved exclusively for reviews and commentaries.
  • Substantial Open Access Fee: For authors whose funders mandate immediate gold open access (such as specific European Horizon Europe or Wellcome Trust grants), the $5,460 USD APC represents a significant budgetary commitment if institutional transformative agreements are unavailable.
  • High Desk-Rejection Rate: The editorial office screens incoming manuscripts rigorously for novelty. Descriptive literature summaries that merely recount published findings without critical synthesis, mechanistic schematics, or resolving contradictory evidence are frequently rejected at triage.
  • Single-Blind Evaluation: The use of single-anonymous review rather than double-blind evaluation may leave the review process vulnerable to unconscious institutional or geographical biases during referee assessment.

Alternatives

Researchers formulating review manuscripts or seeking publication venues in biogerontology have several alternative high-impact options across commercial, society, and open-access publishers. The choice depends heavily on whether the manuscript contains primary data, the target publishing model, and the desired turnaround speed.

The following editorial table contrasts the structural, review, and formatting policies of leading alternative venues in ageing research:

Journal Venue Accepted Content Formats Peer Review Model Typical Review Word Budget Primary Citation System
Ageing Research Reviews Reviews, Short Reviews, Viewpoints only Single-blind (single-anonymous) 8,000–12,000 words Elsevier Harvard (Author-Date)
Nature Aging Primary research articles, Reviews, Perspectives Double-blind option available 5,000–8,000 words Nature numbered Vancouver style
Aging Cell Original research, Review articles, Short reports Single-blind 6,000–8,000 words Wiley Harvard (Author-Date)
npj Aging Primary research, Brief communications, Reviews Single-blind 4,000–6,000 words Nature numbered Vancouver style
GeroScience Original research, Reviews, Meeting reports Single-blind 6,000–10,000 words Springer Basic numbered style
Mechanisms of Ageing and Development Original empirical papers, Reviews, Mini-reviews Single-blind 5,000–8,000 words Elsevier Numbered style

When selecting among these venues, researchers must evaluate specific strategic factors:

  • Primary Data vs. Review Mandate: If your project includes bench experimental findings or clinical trial cohorts, Ageing Research Reviews is disqualified. Authors should instead target Nature Aging for top-tier broad biological impact, Aging Cell for molecular and cellular genetic mechanisms, or Mechanisms of Ageing and Development for biochemical and physiological laboratory studies.
  • Mandatory Open Access Compliance: Authors bound by funder mandates requiring immediate, unembargoed open access under CC BY licenses should assess whether their institution holds a transformative agreement with Elsevier. If not, pure Gold Open Access alternatives such as the Nature Portfolio npj Aging guide or Wiley’s Aging Cell offer dedicated open-access infrastructures with differing APC pricing schedules.
  • Organismal and Medical Breadth: For investigations centered on translational human gerontology, clinical biomarker panels, or interventional healthcare delivery, society-backed journals such as GeroScience (American Aging Association) or specialty journals in neurodegeneration (such as Frontiers in Aging Neuroscience) provide immediate access to clinical and translational reader communities.

The data table below compares the bibliometric, publishing, and economic metrics across these seven leading biogerontology and ageing research periodicals.

Frequently asked questions

What is the Impact Factor of Ageing Research Reviews?

According to Clarivate’s 2024–2025 Journal Citation Reports (JCR), Ageing Research Reviews has a Journal Impact Factor of 15.5. The journal ranks in the first quartile (Q1) of both the “Geriatrics & Gerontology” and “Cell Biology” categories, supported by a Scopus CiteScore of 24.1.

Is Ageing Research Reviews an open access journal?

Ageing Research Reviews is a hybrid journal, not a purely open-access publication. Authors may publish their accepted papers free of charge through the traditional subscription publishing model, or they can choose Gold Open Access by paying an Article Publishing Charge (APC) of $5,460 USD to make their work freely available under Creative Commons licensing.

Does Ageing Research Reviews accept original primary research papers?

No. Ageing Research Reviews strictly enforces a review-only editorial policy. The journal exclusively publishes comprehensive Critical Reviews, Short/Mini Reviews, Viewpoint essays, and systematic reviews or meta-analyses. Primary empirical laboratory papers and clinical trial results are not considered.

What reference style does Ageing Research Reviews require?

The journal uses the Elsevier Harvard author-date citation style. In-text references must state the author surname and year of publication in parentheses (e.g., Smith and Jones, 2022; or Miller et al., 2024 for three or more authors). The bibliography is organized alphabetically at the end of the manuscript using standard ISO 4 journal abbreviations.

What is the peer review model used by Ageing Research Reviews?

The journal employs a single-blind (single-anonymous) peer review workflow. Peer reviewers are informed of the authors’ names, affiliations, and geographic locations during evaluation, but the identities of the reviewers are kept confidential from the authors throughout and following the decision process.

What are the article types accepted by the journal?

The journal considers three primary formats: Critical Reviews (comprehensive syntheses of 8,000 to 12,000 words with mechanistic diagrams), Short Reviews (focused treatments of 4,000 to 6,000 words on emerging developments), and Viewpoints (perspectives and opinion essays). Systematic reviews adhering to PRISMA reporting standards are also considered.

Sources

Data: Biogerontology and Ageing Research Journal Metrics and Publishing Models Comparison

Comparative dataset benchmarking Clarivate Impact Factors, Scopus CiteScores, publishing models, article processing charges (APCs), and thematic scopes across leading international peer-reviewed journals in ageing research, biogerontology, and cellular longevity. Compiled from publisher policies, Clarivate JCR, and Scopus source records.

Period covered: 2024-2026. Coverage: Global.

Biogerontology and Ageing Research Journal Metrics and Publishing Models Comparison
JournalPublisherJournal Impact FactorCiteScorePublishing ModelGold OA APC (USD)Primary Scope
Ageing Research ReviewsElsevier15.524.1Hybrid5460Critical reviews, systematic reviews, and viewpoints on cellular and molecular mechanisms of ageing and age-associated pathologies
Nature AgingSpringer Nature16.621.4Hybrid12290Primary research and reviews across basic, translational, and clinical biology of ageing and longevity
Aging CellWiley / Anatomical Society7.813.9Gold Open Access4700Primary empirical research and reviews exploring biological mechanisms of ageing and longevity pathways
npj AgingNature Portfolio1316.1Gold Open Access3490Cellular and organismal ageing, longevity pathways, and therapeutic interventions in geroscience
GeroScienceSpringer / American Aging Association5.69.6Hybrid4590Biology of ageing, biomedical interventions, and clinical geroscience targeting healthspan
Mechanisms of Ageing and DevelopmentElsevier5.39.8Hybrid3830Primary laboratory reports and reviews on molecular, biochemical, and cellular mechanisms of senescence
BiogerontologySpringer3.87.3Hybrid3990Basic research and conceptual reviews into biological ageing mechanisms, longevity, and age-related decline

Sources

Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · full access

Ask about Ageing Research Reviews: Scope, Impact Factor, APC and Submission Guide

Full access: large monthly usage, up to 10 source passages behind each answer, and MCP and API access for Claude Code, Codex and other CLIs. Cancel any time.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →